Review



foxo3a tm pcdna  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Addgene inc foxo3a tm pcdna
    Par-4 is a direct target of <t>Foxo3a.</t> A – C, Time-course of Par-4 mRNA upregulation following 4-OH Tamoxifen treatment in BT-474 (A), SKBR3 (B), or MCF-7 (C) cells stably expressing Foxo3a TM-ER fusion. D, Western analysis showing Par-4 upregulation 24 hours after 4-OHT treatment. E, Schematic of the Par-4 promoter surrounding the transcriptional start site. Eight regions (~500bp each) were cloned upstream of luciferase for use in reporter gene experiments. Putative Foxo3a binding sites in region 2, 6, and 8 are shown. F, 293T cells were transfected with luciferase constructs containing each promoter region together with empty vector or constitutively active Foxo3a TM, and luciferase expression was measured 24 hours later. pGL3: empty vector (negative control); FHRE: forkhead response element (positive control) G, Chromatin immunoprecipitation (ChIP) analysis of Foxo3a occupancy at indicated regions of the Par-4 promoter in BT-474 cells treated with vehicle or MK-2206 for 24 hours. A distal region (-10 kb) of the Par-4 promoter was used as a negative control, and the Puma promoter was used as a positive control. Data are expressed as fold-enrichment over IgG IP. Significance was determined by Student’s t-test and data are presented as mean plus SD. **, p<0.01; ***, p<0.001.
    Foxo3a Tm Pcdna, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 14 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/foxo3a+tm+pcdna/1319+pcDNA3+flag+FKHRL1+AAA+(Plasmid+%2310709)/pmc05882527-75-9-16
    Average 93 stars, based on 14 article reviews
    foxo3a tm pcdna - by Bioz Stars, 2026-10
    93/100 stars

    Images

    1) Product Images from "Foxo-dependent Par-4 Upregulation Prevents Long-term Survival of Residual Cells Following PI3K-Akt Inhibition"

    Article Title: Foxo-dependent Par-4 Upregulation Prevents Long-term Survival of Residual Cells Following PI3K-Akt Inhibition

    Journal: Molecular cancer research : MCR

    doi: 10.1158/1541-7786.MCR-17-0492

    Par-4 is a direct target of Foxo3a. A – C, Time-course of Par-4 mRNA upregulation following 4-OH Tamoxifen treatment in BT-474 (A), SKBR3 (B), or MCF-7 (C) cells stably expressing Foxo3a TM-ER fusion. D, Western analysis showing Par-4 upregulation 24 hours after 4-OHT treatment. E, Schematic of the Par-4 promoter surrounding the transcriptional start site. Eight regions (~500bp each) were cloned upstream of luciferase for use in reporter gene experiments. Putative Foxo3a binding sites in region 2, 6, and 8 are shown. F, 293T cells were transfected with luciferase constructs containing each promoter region together with empty vector or constitutively active Foxo3a TM, and luciferase expression was measured 24 hours later. pGL3: empty vector (negative control); FHRE: forkhead response element (positive control) G, Chromatin immunoprecipitation (ChIP) analysis of Foxo3a occupancy at indicated regions of the Par-4 promoter in BT-474 cells treated with vehicle or MK-2206 for 24 hours. A distal region (-10 kb) of the Par-4 promoter was used as a negative control, and the Puma promoter was used as a positive control. Data are expressed as fold-enrichment over IgG IP. Significance was determined by Student’s t-test and data are presented as mean plus SD. **, p<0.01; ***, p<0.001.
    Figure Legend Snippet: Par-4 is a direct target of Foxo3a. A – C, Time-course of Par-4 mRNA upregulation following 4-OH Tamoxifen treatment in BT-474 (A), SKBR3 (B), or MCF-7 (C) cells stably expressing Foxo3a TM-ER fusion. D, Western analysis showing Par-4 upregulation 24 hours after 4-OHT treatment. E, Schematic of the Par-4 promoter surrounding the transcriptional start site. Eight regions (~500bp each) were cloned upstream of luciferase for use in reporter gene experiments. Putative Foxo3a binding sites in region 2, 6, and 8 are shown. F, 293T cells were transfected with luciferase constructs containing each promoter region together with empty vector or constitutively active Foxo3a TM, and luciferase expression was measured 24 hours later. pGL3: empty vector (negative control); FHRE: forkhead response element (positive control) G, Chromatin immunoprecipitation (ChIP) analysis of Foxo3a occupancy at indicated regions of the Par-4 promoter in BT-474 cells treated with vehicle or MK-2206 for 24 hours. A distal region (-10 kb) of the Par-4 promoter was used as a negative control, and the Puma promoter was used as a positive control. Data are expressed as fold-enrichment over IgG IP. Significance was determined by Student’s t-test and data are presented as mean plus SD. **, p<0.01; ***, p<0.001.

    Techniques Used: Stable Transfection, Expressing, Western Blot, Clone Assay, Luciferase, Binding Assay, Transfection, Construct, Plasmid Preparation, Negative Control, Positive Control, Chromatin Immunoprecipitation

    Inhibition of the mTOR pathway induces upregulation of Par-4 and Foxo3a. A, BT-474 cells were transduced with lentivirus expressing a control shRNA or one of two shRNAs targeting mTOR. Four days later, cells were treated with vehicle or Lapatinib for 3 days and levels of Par-4 and components of the mTOR pathway were measured by Western blotting. B and C, BT-474, MCF-7, and SKBR3 cells were treated with Torin1 for 2 days and levels of Foxo3a were measured by qRT-PCR (B) or Western blot (C). Significance was determined by Student’s t-test and data are presented as mean plus SD. **, p<0.01; ***, p<0.001.
    Figure Legend Snippet: Inhibition of the mTOR pathway induces upregulation of Par-4 and Foxo3a. A, BT-474 cells were transduced with lentivirus expressing a control shRNA or one of two shRNAs targeting mTOR. Four days later, cells were treated with vehicle or Lapatinib for 3 days and levels of Par-4 and components of the mTOR pathway were measured by Western blotting. B and C, BT-474, MCF-7, and SKBR3 cells were treated with Torin1 for 2 days and levels of Foxo3a were measured by qRT-PCR (B) or Western blot (C). Significance was determined by Student’s t-test and data are presented as mean plus SD. **, p<0.01; ***, p<0.001.

    Techniques Used: Inhibition, Transduction, Expressing, Control, shRNA, Western Blot, Quantitative RT-PCR

    Related Articles

    Expressing:

    Article Title: Foxo-dependent Par-4 Upregulation Prevents Long-term Survival of Residual Cells Following PI3K-Akt Inhibition
    Article Snippet: Plasmids, CRISPR knockout, and lentiviral transduction To generate cells stably expressing tamoxifen-inducible Foxo3a, we cloned HA-FOXO3a TM-ER (a gift from Michael Greenberg; Addgene #8353), a constitutively active form of Foxo3a with mutations in Akt phosphorylation sites (T32A, S253A, S315A) fused to the estrogen receptor, into the lentiviral vector pCDH-EF1-FHC (a gift from Richard Wood; Addgene #64874). .. For transient expression of constitutively active Foxo3a we used FOXO3a TM/pcDNA (a gift from William Sellers; Addgene #10709). .. Myristoylated Akt (pWZL Neo Myr Flag AKT1) was a gift from William Hahn and Jean Zhao (Addgene #20422).

    Article Title: Foxo-dependent Par-4 Upregulation Prevents Long-term Survival of Residual Cells Following PI3K–Akt Inhibition
    Article Snippet: © 2018 American Association for Cancer Research. mcr.aacrjournals.org Downloaded from 8 with mutations in Akt phosphorylation sites (T32A, S253A, S315A) fused to the estrogen receptor, into the lentiviral vector pCDH-EF1-FHC (a gift from Richard Wood; Addgene #64874). .. For transient expression of constitutively active Foxo3a we used FOXO3a TM/pcDNA (a gift from William Sellers; Addgene #10709). .. Myristoylated Akt (pWZL Neo Myr Flag AKT1) was a gift from William Hahn and Jean Zhao (Addgene #20422).



    Similar Products

    foxo3a tm pcdna  (Addgene inc)
    93
    Addgene inc foxo3a tm pcdna
    Par-4 is a direct target of <t>Foxo3a.</t> A – C, Time-course of Par-4 mRNA upregulation following 4-OH Tamoxifen treatment in BT-474 (A), SKBR3 (B), or MCF-7 (C) cells stably expressing Foxo3a TM-ER fusion. D, Western analysis showing Par-4 upregulation 24 hours after 4-OHT treatment. E, Schematic of the Par-4 promoter surrounding the transcriptional start site. Eight regions (~500bp each) were cloned upstream of luciferase for use in reporter gene experiments. Putative Foxo3a binding sites in region 2, 6, and 8 are shown. F, 293T cells were transfected with luciferase constructs containing each promoter region together with empty vector or constitutively active Foxo3a TM, and luciferase expression was measured 24 hours later. pGL3: empty vector (negative control); FHRE: forkhead response element (positive control) G, Chromatin immunoprecipitation (ChIP) analysis of Foxo3a occupancy at indicated regions of the Par-4 promoter in BT-474 cells treated with vehicle or MK-2206 for 24 hours. A distal region (-10 kb) of the Par-4 promoter was used as a negative control, and the Puma promoter was used as a positive control. Data are expressed as fold-enrichment over IgG IP. Significance was determined by Student’s t-test and data are presented as mean plus SD. **, p<0.01; ***, p<0.001.
    Foxo3a Tm Pcdna, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/foxo3a+tm+pcdna/1319+pcDNA3+flag+FKHRL1+AAA+(Plasmid+%2310709)/pmc05882527-75-9-16
    Average 93 stars, based on 1 article reviews
    foxo3a tm pcdna - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    Par-4 is a direct target of Foxo3a. A – C, Time-course of Par-4 mRNA upregulation following 4-OH Tamoxifen treatment in BT-474 (A), SKBR3 (B), or MCF-7 (C) cells stably expressing Foxo3a TM-ER fusion. D, Western analysis showing Par-4 upregulation 24 hours after 4-OHT treatment. E, Schematic of the Par-4 promoter surrounding the transcriptional start site. Eight regions (~500bp each) were cloned upstream of luciferase for use in reporter gene experiments. Putative Foxo3a binding sites in region 2, 6, and 8 are shown. F, 293T cells were transfected with luciferase constructs containing each promoter region together with empty vector or constitutively active Foxo3a TM, and luciferase expression was measured 24 hours later. pGL3: empty vector (negative control); FHRE: forkhead response element (positive control) G, Chromatin immunoprecipitation (ChIP) analysis of Foxo3a occupancy at indicated regions of the Par-4 promoter in BT-474 cells treated with vehicle or MK-2206 for 24 hours. A distal region (-10 kb) of the Par-4 promoter was used as a negative control, and the Puma promoter was used as a positive control. Data are expressed as fold-enrichment over IgG IP. Significance was determined by Student’s t-test and data are presented as mean plus SD. **, p<0.01; ***, p<0.001.

    Journal: Molecular cancer research : MCR

    Article Title: Foxo-dependent Par-4 Upregulation Prevents Long-term Survival of Residual Cells Following PI3K-Akt Inhibition

    doi: 10.1158/1541-7786.MCR-17-0492

    Figure Lengend Snippet: Par-4 is a direct target of Foxo3a. A – C, Time-course of Par-4 mRNA upregulation following 4-OH Tamoxifen treatment in BT-474 (A), SKBR3 (B), or MCF-7 (C) cells stably expressing Foxo3a TM-ER fusion. D, Western analysis showing Par-4 upregulation 24 hours after 4-OHT treatment. E, Schematic of the Par-4 promoter surrounding the transcriptional start site. Eight regions (~500bp each) were cloned upstream of luciferase for use in reporter gene experiments. Putative Foxo3a binding sites in region 2, 6, and 8 are shown. F, 293T cells were transfected with luciferase constructs containing each promoter region together with empty vector or constitutively active Foxo3a TM, and luciferase expression was measured 24 hours later. pGL3: empty vector (negative control); FHRE: forkhead response element (positive control) G, Chromatin immunoprecipitation (ChIP) analysis of Foxo3a occupancy at indicated regions of the Par-4 promoter in BT-474 cells treated with vehicle or MK-2206 for 24 hours. A distal region (-10 kb) of the Par-4 promoter was used as a negative control, and the Puma promoter was used as a positive control. Data are expressed as fold-enrichment over IgG IP. Significance was determined by Student’s t-test and data are presented as mean plus SD. **, p<0.01; ***, p<0.001.

    Article Snippet: For transient expression of constitutively active Foxo3a we used FOXO3a TM/pcDNA (a gift from William Sellers; Addgene #10709).

    Techniques: Stable Transfection, Expressing, Western Blot, Clone Assay, Luciferase, Binding Assay, Transfection, Construct, Plasmid Preparation, Negative Control, Positive Control, Chromatin Immunoprecipitation

    Inhibition of the mTOR pathway induces upregulation of Par-4 and Foxo3a. A, BT-474 cells were transduced with lentivirus expressing a control shRNA or one of two shRNAs targeting mTOR. Four days later, cells were treated with vehicle or Lapatinib for 3 days and levels of Par-4 and components of the mTOR pathway were measured by Western blotting. B and C, BT-474, MCF-7, and SKBR3 cells were treated with Torin1 for 2 days and levels of Foxo3a were measured by qRT-PCR (B) or Western blot (C). Significance was determined by Student’s t-test and data are presented as mean plus SD. **, p<0.01; ***, p<0.001.

    Journal: Molecular cancer research : MCR

    Article Title: Foxo-dependent Par-4 Upregulation Prevents Long-term Survival of Residual Cells Following PI3K-Akt Inhibition

    doi: 10.1158/1541-7786.MCR-17-0492

    Figure Lengend Snippet: Inhibition of the mTOR pathway induces upregulation of Par-4 and Foxo3a. A, BT-474 cells were transduced with lentivirus expressing a control shRNA or one of two shRNAs targeting mTOR. Four days later, cells were treated with vehicle or Lapatinib for 3 days and levels of Par-4 and components of the mTOR pathway were measured by Western blotting. B and C, BT-474, MCF-7, and SKBR3 cells were treated with Torin1 for 2 days and levels of Foxo3a were measured by qRT-PCR (B) or Western blot (C). Significance was determined by Student’s t-test and data are presented as mean plus SD. **, p<0.01; ***, p<0.001.

    Article Snippet: For transient expression of constitutively active Foxo3a we used FOXO3a TM/pcDNA (a gift from William Sellers; Addgene #10709).

    Techniques: Inhibition, Transduction, Expressing, Control, shRNA, Western Blot, Quantitative RT-PCR